Marc Mejias
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
Journal: Gastroenterology
Published: July 15, 2019
Pericytes in the Gut.
Journal: Advances in experimental medicine and biology
Published: April 03, 2019
Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension.
Journal: Gut
Published: November 24, 2015
Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Journal: Gastroenterology
Published: April 09, 2015
Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
Journal: Gut
Published: May 23, 2014
Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Journal: Hepatology (Baltimore, Md.)
Published: September 12, 2013
Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: March 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026